Challenging Half for Biotech Sector Following Major US Trade and FDA Changes and Uncertainties Ahead

Is a Biotech Sector Resurgence Underway?

A Record $1.2 Billion Raised in First Half 2024

Volatile Half for Australian Biotech Sector

Capital Starts Return to Biotech Sector